Searched for
SUN PHARMACEUTICALS HALOL
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...- US FDA lists Sun Pharma's Halol unit under 'import alert'The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that ...
- Sun Pharma drops 3% as USFDA initiates action against Halol facilityUSFDA inspected the facility from December 3 to December 13 and had issued eight observations, the company had earlier said in a regulatory...
- USFDA conducting inspection of Mohali plant: Sun PharmaThe inspection by the United States Food and Drug Administration (USFDA) started on September 10, 2018 and is ongoing, Sun Pharma said in a...
- Sun Pharma gets 6 observations by USFDA for its Halol facility"At the conclusion of the inspection, the agency issued a Form 483, with six observations," it added.
- USFDA conducts inspection of Sun Pharma’s Halol site: SourcesThe USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes.
- Reduce Sun Pharma, target Rs 482: Elara CapitalReduce Sun Pharmaceutical Industries Ltd. at a price target of Rs 482.0 .
- Reduce Sun Pharma, target Rs 450: IIFLReduce Sun Pharmaceutical Industries Ltd. at a price target of Rs 450.0 .
- Is Sun Pharma's Halol site close to a rebound?About 40% of the US revenues of Sun Pharmaceutical Industries, India's most valuable pharmaceutical company, is linked to its Halol site.
- Buy Sun Pharma, with a target of Rs 750: Bank of America Merrill LynchBofA-ML maintains buy rating on Sun Pharma but slashed its 12-month target price to Rs 750 from Rs 790 earlier.
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- Sun Pharma trades higher after falling 8% in past four sessionsSun Pharma on Wednesday said the US regulator had issued an observation letter after the completion of inspection of its Halol facility.
- FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
- Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
- Buy Sun Pharmaceutical Industries Ltd., target Rs 945.0 : SharekhanSharekhan sees 19% upside in Sun Pharma as the management is confident of resolving the Halol issue
- Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspectionDrug major Sun Pharmaceutical Industries may ask the US health regulator in the first quarter of next fiscal for re-inspection of its Halol...
- Brokers take a shine to Sun Pharma post 40% fallSun Pharma, one of the top performing pharmaceutical stocks historically, fell to a low of `706 in November after hitting `1,200 in April t...
- Brokers turn bullish on Sun PharmaMorgan Stanley said it was overweight on the stock and there was 22% upside in the counter in the next 12 months. The brokerage house has s...
- Sun Pharma recalls 5,322 bottles of Ketorolac eye drop in USLast month, the drug major had recalled 3,263 bottles of epilepsy drug in US market for failing "dissolution specifications".
Load More
